关注
Jill Kolesar
Jill Kolesar
Professor of Pharmacy Practice and Science, University of Kentucky
在 uky.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Increased adiposity in animals due to a human virus
NV Dhurandhar, BA Israel, JM Kolesar, GF Mayhew, ME Cook, ...
International journal of obesity 24 (8), 989-996, 2000
3192000
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study
SJ Lubner, MR Mahoney, JL Kolesar, NK LoConte, GP Kim, HC Pitot, ...
Journal of Clinical Oncology 28 (21), 3491-3497, 2010
3162010
Pharmacotherapy principles & practice
MA Edited by Chisholm-Burns, PM Malone, TL Schwinghammer, ...
McGraw-Hill Education, 2016
2812016
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial
A Argiris, M Ghebremichael, J Gilbert, JW Lee, K Sachidanandam, ...
Journal of Clinical Oncology 31 (11), 1405-1414, 2013
2282013
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone …
C Sweeney, G Liu, C Yiannoutsos, J Kolesar, D Horvath, MJ Staab, K Fife, ...
Clinical cancer research 11 (18), 6625-6633, 2005
2182005
Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14. 18-IL2 immunotherapy
DC Delgado, JA Hank, J Kolesar, D Lorentzen, J Gan, S Seo, KM Kim, ...
Cancer research 70 (23), 9554-9561, 2010
1992010
A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer
L Van Ummersen, K Binger, J Volkman, R Marnocha, K Tutsch, J Kolesar, ...
Clinical Cancer Research 10 (22), 7450-7456, 2004
1912004
Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion
DG McNeel, J Eickhoff, FT Lee, DM King, D Alberti, JP Thomas, A Friedl, ...
Clinical Cancer Research 11 (21), 7851-7860, 2005
1902005
Transmissibility of adenovirus-induced adiposity in a chicken model
NV Dhurandhar, BA Israel, JM Kolesar, G Mayhew, ME Cook, RL Atkinson
International journal of obesity 25 (7), 990-996, 2001
1642001
Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study
AM Traynor, S Dubey, JC Eickhoff, JM Kolesar, K Schell, MS Huie, ...
Journal of Thoracic Oncology 4 (4), 522-526, 2009
1562009
Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology
RA Mathai, RVS Vidya, BS Reddy, L Thomas, K Udupa, J Kolesar, M Rao
Journal of clinical medicine 8 (3), 373, 2019
1512019
A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs
HC Shin, AWG Alani, H Cho, Y Bae, JM Kolesar, GS Kwon
Molecular pharmaceutics 8 (4), 1257-1265, 2011
1462011
Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer
AJ Tevaarwerk, JM Kolesar
Clinical therapeutics 31, 2332-2348, 2009
1422009
Opportunities for drug repositioning from phenome-wide association studies
M Rastegar-Mojarad, Z Ye, JM Kolesar, SJ Hebbring, SM Lin
Nature biotechnology 33 (4), 342-345, 2015
1322015
A phase II trial of Triapine®(NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503
AM Traynor, JW Lee, GK Bayer, JM Tate, SP Thomas, M Mazurczak, ...
Investigational new drugs 28, 91-97, 2010
1222010
Prevention and treatment of chemotherapy-induced peripheral neuropathy
J Piccolo, JM Kolesar
American journal of health-system pharmacy 71 (1), 19-25, 2014
1182014
Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma
SA Kavanaugh, LA White, JM Kolesar
American journal of health-system pharmacy 67 (10), 793-797, 2010
1162010
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients
E Messing, JR Gee, DR Saltzstein, KM Kim, A diSant'Agnese, J Kolesar, ...
Cancer prevention research 5 (4), 621-630, 2012
1082012
Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer
AM Traynor, JH Schiller, LP Stabile, JM Kolesar, JC Eickhoff, S Dacic, ...
Lung cancer 64 (1), 51-59, 2009
1072009
Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma
JJ Hiles, JM Kolesar
American Journal of Health-System Pharmacy 65 (2), 123-131, 2008
1032008
系统目前无法执行此操作,请稍后再试。
文章 1–20